All Stories

  1. Antimicrobial self-healing injectable hydrogels based on chitosan, collagen, and polyvinyl alcohol for chronic wound treatment
  2. Targeting the Hippo/YAP Pathway: A Promising Approach for Cancer Therapy and Beyond
  3. Repurposing Poloxamers as Antimicrobial Agents: A Comprehensive Review of Mechanisms and Applications
  4. Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies
  5. Influencia del grado de desacetilación del quitosano en la síntesis de nanopartículas para aplicaciones farmacéuticas
  6. Magnolol and its semi-synthetic derivatives: a comprehensive review of anti-cancer mechanisms, pharmacokinetics, and future therapeutic potential
  7. Maytansinoids in cancer therapy: advancements in antibody–drug conjugates and nanotechnology-enhanced drug delivery systems
  8. Skin Disorders and Quality of Life: An Overview
  9. D1 Receptor Functional Asymmetry at Striatonigral Neurons: A Neurochemical and Behavioral Study in Male Wistar Rats
  10. Nanoparticle and microparticle-based systems for enhanced oral insulin delivery: A systematic review and meta-analysis
  11. Unlocking the biological potential of methyl antcinate A: a new frontier in cancer and inflammation application
  12. Current Overview of Spinocerebellar Ataxia Type 7 in Mexican Population: Challenges in Specialized Care for a Rare Disease
  13. Unrevealing Lithium Repositioning in the Hallmarks of Cancer: Effects of Lithium Salts (LiCl and Li2CO3) in an In Vitro Cervical Cancer Model
  14. Natural products‐based antiangiogenic agents: New frontiers in cancer therapy
  15. Cacalol Acetate as Anticancer Agent: Antiproliferative, Pro-Apoptotic, Cytostatic, and Anti-Migratory Effects
  16. Cacalol Acetate as Anticancer Agent: Anti-proliferative, Pro-apoptotic, Cytostatic and Anti-migratory Effects
  17. Biopolymeric Insulin Membranes for Antimicrobial, Antioxidant, and Wound Healing Applications
  18. Polymeric nanoparticles decorated with fragmented chitosan as modulation systems for neuronal drug uptake
  19. Genipin’s potential as an anti-cancer agent: from phytochemical origins to clinical prospects
  20. New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives
  21. Nutritional Sources and Anticancer Potential of Phenethyl Isothiocyanate: Molecular Mechanisms and Therapeutic Insights
  22. Review of the anticancer properties of 6‐shogaol: Mechanisms of action in cancer cells and future research opportunities
  23. Optimize the parameters for the synthesis by the ionic gelation technique, purification, and freeze-drying of chitosan-sodium tripolyphosphate nanoparticles for biomedical purposes
  24. Modulation of D3R Splicing, Signaling, and Expression by D1R through PKA→PTB Phosphorylation
  25. Skin Disorders and Quality of Life: An Overview
  26. Dopamine D3 receptor modulates D2 receptor effects on cAMP and GABA release at striatopallidal terminals—Modulation by the Ca2+–Calmodulin–CaMKII system
  27. Essential-Oils-Loaded Biopolymeric Nanoparticles as Strategies for Microbial and Biofilm Control: A Current Status
  28. Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
  29. Novel ultra-stretchable and self-healing crosslinked poly (ethylene oxide)-cationic guar gum hydrogel
  30. 3,3′-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways
  31. Recombinant Antibodies to Face SARS-CoV-2 Syndemic
  32. High Levels of Anxiety, Depression, Risk of Suicide, and Implications for Treatment in Patients with Lamellar Ichthyosis
  33. Neopeltolide and its synthetic derivatives: a promising new class of anticancer agents
  34. PEG 400:Trehalose Coating Enhances Curcumin-Loaded PLGA Nanoparticle Internalization in Neuronal Cells
  35. Enhancing chemical and physical stability of pharmaceuticals using freeze-thaw method: challenges and opportunities for process optimization through quality by design approach
  36. Current Status of the Therapeutic Approach for Dysmenorrhea
  37. Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain
  38. Lithium: A Promising Anticancer Agent
  39. Discovering the effect of solvents on poly(2-aminoethyl methacrylate) grafting onto chitosan for an in vitro skin model
  40. Study of Traditional Uses, Extraction Procedures, Phytochemical Constituents, and Pharmacological Properties of Tiliacora triandra
  41. Preparation of chitosan-graft N-hydroxyethyl acrylamide copolymers as an in vitro-engineered skin
  42. Repositioning of drugs for Parkinson’s disease and pharmaceutical nanotechnology tools for their optimization
  43. Presynaptic nigral GPR55 receptors stimulate [ 3 H]‐GABA release through [ 3 H]‐cAMP production and PKA activation and promote motor behavior
  44. Indole-3-Carbinol, a Phytochemical Aryl Hydrocarbon Receptor-Ligand, Induces the mRNA Overexpression of UBE2L3 and Cell Proliferation Arrest
  45. The high methylation level of a novel 151-bp CpG island in the ESR1 gene promoter is associated with a poor breast cancer prognosis
  46. A poly (saccharide-ester-urethane) scaffold for mammalian cell growth
  47. Gamma radiation-induced grafting of poly(2-aminoethyl methacrylate) onto chitosan: A comprehensive study of a polyurethane scaffold intended for skin tissue engineering
  48. Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer
  49. Alterations in mental health and quality of life in patients with skin disorders: a narrative review
  50. Therapeutic Applications of Terpenes on Inflammatory Diseases
  51. A NEW FORMULATION OF CINNAMON OIL AND CHITOSAN DEPOLYMERIZED AGAINST OPPORTUNISTIC MICROORGANISMS DURING WOUND HEALING
  52. Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses
  53. Current progress of self-healing polymers for medical applications in tissue engineering
  54. Insights into Terminal Sterilization Processes of Nanoparticles for Biomedical Applications
  55. Antioxidant potential of family Cucurbitaceae with special emphasis on Cucurbita genus: A key to alleviate oxidative stress‐mediated disorders
  56. Cordyceps spp.: A Review on Its Immune-Stimulatory and Other Biological Potentials
  57. Association of TLR4 gene polymorphisms with sepsis after a burn injury: findings of the functional role of rs2737190 SNP
  58. Curcumin for parkinson´s disease: potential therapeutic effects, molecular mechanisms, and nanoformulations to enhance its efficacy
  59. Development of a guar gum film with lysine clonixinate for periodontal treatments
  60. Development of a xanthan gum film for the possible treatment of vaginal infections
  61. Development of films from natural sources for infections during wound healing
  62. Physicochemical and biological characterization of a xanthan gum-polyvinylpyrrolidone hydrogel obtained by gamma irradiation
  63. Radiation-induced graft polymerization of elastin onto polyvinylpyrrolidone as a possible wound dressing
  64. Synthesis by gamma irradiation of hyaluronic acid-polyvinyl alcohol hydrogel for biomedical applications
  65. Repurposing of Drug Candidates for Treatment of Skin Cancer
  66. Increased risk of depression and impairment in quality of life in patients with lamellar ichthyosis
  67. Dopamine D4 receptor modulates inhibitory transmission in pallido‐pallidal terminals and regulates motor behavior
  68. Gamma radiation-induced grafting of n-hydroxyethyl acrylamide onto poly(3-hydroxybutyrate): A companion study on its polyurethane scaffolds meant for potential skin tissue engineering applications
  69. Chitosan-decorated nanoparticles for drug delivery
  70. A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier
  71. Radiation-induced PEGylated Ethambutol Has Low Antimycobacterial Activity in Vitro
  72. RECENT ADVANCES IN ELASTIN-BASED BIOMATERIALS
  73. Coexistence of Fragile-X Syndrome, 8p23.1 Deletion, and Balanced Translocation t(7;10)(p10;q24) in a Single Family
  74. Xanthan gum in drug release
  75. Hyaluronic acid in wound dressings
  76. High prevalence of autosomal recessive congenital ichthyosis in a Mexican population caused by a new mutation in the TGM1 gene: epidemiological evidence of a founder effect
  77. Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases
  78. Altered Plasma Acylcarnitines and Amino Acids Profile in Spinocerebellar Ataxia Type 7
  79. Coexistence of D 3 R typical and atypical signaling in striatonigral neurons during dopaminergic denervation. Correlation with D 3 nf expression changes
  80. Breast cancer-related single-nucleotide polymorphism and their risk contribution in Mexican women
  81. D 2 autoreceptor switches CB 2 receptor effects on [ 3 H]‐dopamine release in the striatum
  82. Non-invasive methods for evaluation of skin manifestations in patients with ichthyosis
  83. Pharmacological treatments for cutaneous manifestations of inherited ichthyoses
  84. Blockade of Intranigral and Systemic D3 Receptors Stimulates Motor Activity in the Rat Promoting a Reciprocal Interaction Among Glutamate, Dopamine, and GABA
  85. Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects
  86. Development and Evaluation of Alginate Membranes with Curcumin-Loaded Nanoparticles for Potential Wound-Healing Applications
  87. Modifications in Vaginal Microbiota and Their Influence on Drug Release: Challenges and Opportunities
  88. Oropharyngeal dysphagia in early stages of myotonic dystrophy type 1
  89. Presynaptic Control of [3H]-Glutamate Release by Dopamine Receptor Subtypes in the Rat Substantia Nigra. Central Role of D1 and D3 Receptors
  90. Formulations of Curcumin Nanoparticles for Brain Diseases
  91. Effects of Physical Rehabilitation in Patients with Spinocerebellar Ataxia Type 7
  92. Non-invasive analysis of skin mechanical properties in patients with lamellar ichthyosis
  93. Comprehensive mapping of human body skin hydration: A pilot study
  94. Presynaptic cannabinoid CB2 receptors modulate [3 H]-Glutamate release at subthalamo-nigral terminals of the rat
  95. From traditional biochemical signals to molecular markers for detection of sepsis after burn injuries
  96. Origin of the myotonic dystrophy type 1 mutation in Mexican population and influence of Amerindian ancestry on CTG repeat allelic distribution
  97. Presynaptic Dopamine D2 Receptors Modulate [ 3 H]GABA Release at StriatoPallidal Terminals via Activation of PLC → IP3 → Calcineurin and Inhibition of AC → cAMP → PKA Signaling Cascades
  98. Nanotechnology As Potential Tool for siRNA Delivery in Parkinson's Disease
  99. Cannabinoid-induced depression of synaptic transmission is switched to stimulation when dopaminergic tone is increased in the globus pallidus of the rodent
  100. Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain
  101. Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca2+ dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat
  102. Detección de la duplicación del gen PMP22 en pacientes con neuropatía periférica: estudio en la población mexicana
  103. Presynaptic CaMKIIα modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a Ca2+ dependent manner
  104. Origin of the Spinocerebellar Ataxia Type 7 Gene Mutation in Mexican Population
  105. GABAB receptors modulate depolarization-stimulated [3H]glutamate release in slices of the pars reticulata of the rat substantia nigra
  106. L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors